These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11002229)

  • 21. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
    Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
    J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of the course of quality of life during therapy in women with primary breast cancer.
    Wöckel A; Schwentner L; Krockenberger M; Kreienberg R; Janni W; Wischnewsky M; Thorsten K; Felix F; Riccardo F; Blettner M; Singer S
    Qual Life Res; 2017 Aug; 26(8):2201-2208. PubMed ID: 28386772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
    Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
    Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?
    Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C
    Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.
    Fransson P
    Acta Oncol; 2005; 44(4):355-61. PubMed ID: 16120544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
    Fransson P
    Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
    Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study.
    Tribius S; Raguse M; Voigt C; Münscher A; Gröbe A; Petersen C; Krüll A; Bergelt C; Singer S
    Strahlenther Onkol; 2015 Jun; 191(6):501-10. PubMed ID: 25747264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
    Conaglen HM; de Jong D; Hartopeanu C; Conaglen JV; Tyrie LK
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):197-204. PubMed ID: 23183305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study.
    Majumder K; Nilsson S; Johansson H; Ullén A; Lennernäs B; Bergenmar M; Brandberg Y
    Eur J Cancer; 2016 Sep; 65():43-51. PubMed ID: 27459586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer.
    Dieperink KB; Hansen S; Wagner L; Johansen C; Andersen KK; Hansen O
    Acta Oncol; 2012 Jul; 51(6):722-9. PubMed ID: 22793038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients.
    Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.